Novavax stock jumped at much as 18% Tuesday after the company initiated testing of its coronavirus vaccine candidate in people. The biotech anticipates providing a first look in July at what sort of immune responses are generated.
Novavax jumps as human testing begins on coronavirus vaccine
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over